{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T04:24:31Z","timestamp":1786940671004,"version":"build-2736575974"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T00:00:00Z","timestamp":1781049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T00:00:00Z","timestamp":1786924800000},"content-version":"vor","delay-in-days":68,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Cardiovascular disease is the leading cause of death in patients with chronic kidney disease and those on peritoneal dialysis (PD), with insulin resistance contributing significantly to adverse outcomes. This study evaluates the triglyceride-glucose (TyG) index as a prognostic marker for metabolic dysfunction in PD patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We studied two patient cohorts: 278 new PD patients and 178 prevalent ones. TyG index values were calculated by a validated formula. The patients were followed for 28.0\u2009\u00b1\u200912.6 (incident PD cohort) and 43.9\u2009\u00b1\u200937.6\u2009months (prevalent PD cohort) for survival and hospitalization.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The mean TyG index was 8.70\u2009\u00b1\u20090.61 and 9.01\u2009\u00b1\u20090.72 in the new and prevalent PD cohort, respectively (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.0001). In the incident PD cohort, the 2-year patient survival rates for quartiles I to IV of TyG were 84.0%, 85.9%, 79.8%, and 73.8%, respectively (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.045). However, after adjustment for confounders, TyG was not an independent predictor of patient survival (adjusted hazard ratio 0.958, 95% confidence interval 0.732 to 1.123,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.753). In the prevalent PD cohort, the 2-year patient survival rates for quartiles I to IV of TyG were 68.9%, 75.0%, 84.4%, and 75.0%, respectively (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.364). In both cohorts, TyG index showed no significant association with technique survival rate, hospitalization rates, duration of hospitalization, or peritonitis rates.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The TyG index was higher in prevalent PD patients but was not an independent predictor of patient or technique survival, hospitalization, or peritonitis rate after multivariate adjustment. Although correlated with metabolic parameters, the TyG index did not serve as a prognostic marker in PD patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12882-026-05110-w","type":"journal-article","created":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T09:46:07Z","timestamp":1781084767000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Triglyceride-glucose index and the outcome of peritoneal dialysis patients: analysis of two cohorts"],"prefix":"10.1186","volume":"27","author":[{"given":"Mi\u0142osz","family":"Miedziaszczyk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack Kit-Chung","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Winston Wing-Shing","family":"Fung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gordon Chun-Kau","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai-Ming","family":"Chow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheuk-Chun","family":"Szeto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,10]]},"reference":[{"issue":"9491","key":"5110_CR1","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1016\/S0140-6736(05)67402-8","volume":"366","author":"KG Alberti","year":"2005","unstructured":"Alberti KG, Zimmet P, Shaw J, IDF Epidemiology Task Force Consensus Group. The metabolic syndrome-a new worldwide definition. Lancet. 2005, Sep, 24\u201330;366(9491):1059\u201362.","journal-title":"Lancet"},{"issue":"14","key":"5110_CR2","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1016\/j.jacc.2010.05.034","volume":"56","author":"S Mottillo","year":"2010","unstructured":"Mottillo S, Filion KB, Genest J, Joseph L, Pilote L, Poirier P, et al. The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis. J Am Coll Cardiol. 2010;56(14):1113\u201332. https:\/\/doi.org\/10.1016\/j.jacc.2010.05.034.","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"5110_CR3","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1093\/ndtplus\/sfn073","volume":"1","author":"PK Li","year":"2008","unstructured":"Li PK, Kwan BC, Szeto CC, Ko GT. Metabolic syndrome in peritoneal dialysis patients. NDT Plus. 2008;1(4):206\u201314. https:\/\/doi.org\/10.1093\/ndtplus\/sfn073.","journal-title":"NDT Plus"},{"issue":"4","key":"5110_CR4","doi-asserted-by":"publisher","first-page":"779","DOI":"10.2215\/CJN.06620613","volume":"9","author":"CC Szeto","year":"2014","unstructured":"Szeto CC, Kwan BC, Chow KM, Leung CB, Cheng MS, Law MC, et al. Metabolic syndrome in peritoneal dialysis patients: choice of diagnostic criteria and prognostic implications. Clin J Am Soc Nephrol. 2014;9(4):779\u201387.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3","key":"5110_CR5","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1007\/s11255-023-03790-z","volume":"56","author":"Q Du","year":"2024","unstructured":"Du Q, Jiang Y, Liu Y. Prevalence of metabolic syndrome in patients with end-stage renal disease: a systematic review and meta-analysis. Int Urol Nephrol. 2024;56(3):1057\u201369. https:\/\/doi.org\/10.1007\/s11255-023-03790-z.","journal-title":"Int Urol Nephrol"},{"issue":"2","key":"5110_CR6","first-page":"e61201","volume":"16","author":"A Sanguankeo","year":"2018","unstructured":"Sanguankeo A, Upala S. Metabolic syndrome increases mortality risk in dialysis patients: a systematic review and meta-analysis. Int J Endocrinol Metab. 2018;16(2):e61201.","journal-title":"Int J Endocrinol Metab"},{"issue":"7","key":"5110_CR7","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1002\/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S","volume":"15","author":"KG Alberti","year":"1998","unstructured":"Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation. Diabet Med. 1998;15(7):539\u201353. https:\/\/doi.org\/10.1002\/(SICI)1096-9136(199807)15:7%26lt;539::AID-DIA668%26gt;3.0.CO;2-S.","journal-title":"Diabet Med"},{"key":"5110_CR8","doi-asserted-by":"crossref","unstructured":"Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA. 2001;285(19):2486\u201397.","DOI":"10.1001\/jama.285.19.2486"},{"issue":"4","key":"5110_CR9","doi-asserted-by":"publisher","first-page":"e518","DOI":"10.1016\/j.jacl.2024.04.130","volume":"18","author":"B Adams-Huet","year":"2024","unstructured":"Adams-Huet B, Zubir\u00e1n R, Remaley AT, Jialal I. The triglyceride-glucose index is superior to homeostasis model assessment of insulin resistance in predicting metabolic syndrome in an adult population in the United States. J Clin Lipidol. 2024;18(4):e518\u201324. https:\/\/doi.org\/10.1016\/j.jacl.2024.04.130.","journal-title":"J Clin Lipidol"},{"issue":"3","key":"5110_CR10","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.numecd.2021.11.017","volume":"32","author":"DH Son","year":"2022","unstructured":"Son DH, Lee HS, Lee YJ, Lee JH, Han JH. Comparison of triglyceride-glucose index and HOMA-IR for predicting prevalence and incidence of metabolic syndrome. Nutr Metab Cardiovasc Dis. 2022;32(3):596\u2013604. https:\/\/doi.org\/10.1016\/j.numecd.2021.11.017.","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"1","key":"5110_CR11","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/s12933-022-01546-0","volume":"21","author":"X Liu","year":"2022","unstructured":"Liu X, Tan Z, Huang Y, Zhao H, Liu M, Yu P, et al. Relationship between the triglyceride-glucose index and risk of cardiovascular diseases and mortality in the general population: a systematic review and meta-analysis. Cardiovasc Diabetol. 2022;21(1):124. https:\/\/doi.org\/10.1186\/s12933-022-01546-0.","journal-title":"Cardiovasc Diabetol"},{"issue":"11","key":"5110_CR12","doi-asserted-by":"publisher","first-page":"2446","DOI":"10.1016\/j.numecd.2024.06.010","volume":"34","author":"MK Blicher","year":"2024","unstructured":"Blicher MK, Frary C, Pareek M, Stidsen JV, Vishram-Nielsen JKK, Rasmussen S, et al. Triglyceride-glucose index improves risk prediction beyond traditional risk factors and hypertension mediated organ damage in healthy adults. Nutr Metab Cardiovasc Dis. 2024;34(11):2446\u201354. https:\/\/doi.org\/10.1016\/j.numecd.2024.06.010.","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"2","key":"5110_CR13","doi-asserted-by":"publisher","first-page":"e470","DOI":"10.1210\/clinem\/dgae170","volume":"110","author":"L D\u2019Elia","year":"2025","unstructured":"D\u2019Elia L, Masulli M, Virdis A, Casiglia E, Tikhonoff V, Angeli F, et al. Triglyceride-glucose index and mortality in a large regional-based Italian database (URRAH project). J Clin Endocrinol Metab. 2025;110(2):e470\u201377. https:\/\/doi.org\/10.1210\/clinem\/dgae170.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"5110_CR14","doi-asserted-by":"publisher","first-page":"sfaf016","DOI":"10.1093\/ckj\/sfaf016","volume":"18","author":"YH Lee","year":"2025","unstructured":"Lee YH, Kang SH, Kim DK, Kim JS, Jeong KH, Kim YG, et al. Cardiovascular risk prediction in hemodialysis patients using the triglyceride-glucose index: a multicenter prospective cohort study. Clin Kidney J. 2025;18(3):sfaf016. https:\/\/doi.org\/10.1093\/ckj\/sfaf016.","journal-title":"Clin Kidney J"},{"key":"5110_CR15","doi-asserted-by":"publisher","first-page":"e18781","DOI":"10.7717\/peerj.18781","volume":"13","author":"X Chi","year":"2025","unstructured":"Chi X, Chen S, Huang Z, Zhou R, Su Z, Mai Q, et al. Analysis of the correlation between the serum triglyceride glucose index and the risk of death in patients on maintenance hemodialysis: a retrospective cohort study. PeerJ. 2025;13:e18781. https:\/\/doi.org\/10.7717\/peerj.18781.","journal-title":"PeerJ"},{"issue":"1","key":"5110_CR16","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1186\/s40001-023-01410-1","volume":"28","author":"E Xie","year":"2023","unstructured":"Xie E, Ye Z, Wu Y, Zhao X, Li Y, Shen N, et al. Association of triglyceride-glucose index with coronary severity and mortality in patients on dialysis with coronary artery disease. Eur J Med Res. 2023;28(1):437. https:\/\/doi.org\/10.1186\/s40001-023-01410-1.","journal-title":"Eur J Med Res"},{"issue":"1","key":"5110_CR17","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1186\/s12944-023-01892-2","volume":"22","author":"C Zhan","year":"2023","unstructured":"Zhan C, Peng Y, Ye H, Diao X, Yi C, Guo Q, et al. Triglyceride glucose-body mass index and cardiovascular mortality in patients undergoing peritoneal dialysis: a retrospective cohort study. Lipids Health Dis. 2023;22(1):143. https:\/\/doi.org\/10.1186\/s12944-023-01892-2.","journal-title":"Lipids Health Dis"},{"issue":"4","key":"5110_CR18","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1159\/000500979","volume":"44","author":"Z Yan","year":"2019","unstructured":"Yan Z, Yu D, Cai Y, Shang J, Qin R, Xiao J, et al. Triglyceride glucose index predicting cardiovascular mortality in Chinese initiating peritoneal dialysis: a cohort study. Kidney Blood Press Res. 2019;44(4):669\u201378. https:\/\/doi.org\/10.1159\/000500979.","journal-title":"Kidney Blood Press Res"},{"issue":"2","key":"5110_CR19","doi-asserted-by":"publisher","first-page":"2267127","DOI":"10.1080\/0886022X.2023.2267127","volume":"45","author":"G Liu","year":"2023","unstructured":"Liu G, Yan Q, Wang R, Li D, Cong J, Chen X. Elevated triglyceride-glucose index predisposes to the initial episode of peritonitis in chronic peritoneal dialysis patients. Ren Fail. 2023;45(2):2267127. https:\/\/doi.org\/10.1080\/0886022X.2023.2267127.","journal-title":"Ren Fail"},{"issue":"1","key":"5110_CR20","doi-asserted-by":"publisher","first-page":"sfae362","DOI":"10.1093\/ckj\/sfae362","volume":"18","author":"Z Yang","year":"2024","unstructured":"Yang Z, Ng JK, Fung WW, Chan GC, Chow KM, Szeto CC. Change in adiposity indices after 1 year of peritoneal dialysis: a single-center cohort study. Clin Kidney J. 2024;18(1):sfae362.","journal-title":"Clin Kidney J"},{"key":"5110_CR21","doi-asserted-by":"publisher","first-page":"923","DOI":"10.2147\/CLEP.S218697","volume":"11","author":"J Pylv\u00e4l\u00e4inen","year":"2019","unstructured":"Pylv\u00e4l\u00e4inen J, Talala K, Murtola T, Taari K, Raitanen J, Tammela TL, et al. Charlson comorbidity index based on hospital episode statistics performs adequately in predicting mortality, but its discriminative ability diminishes over time. Clin Epidemiol. 2019;11:923\u201332.","journal-title":"Clin Epidemiol"},{"issue":"4","key":"5110_CR22","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1089\/met.2008.0034","volume":"6","author":"LE Simental-Mend\u00eda","year":"2008","unstructured":"Simental-Mend\u00eda LE, Rodr\u00edguez-Mor\u00e1n M, Guerrero-Romero F. The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects. Metab Syndr Relat Disord. 2008;6(4):299\u2013304. https:\/\/doi.org\/10.1089\/met.2008.0034.","journal-title":"Metab Syndr Relat Disord"},{"issue":"2","key":"5110_CR23","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1159\/000169582","volume":"7","author":"ZJ Twardowski","year":"2008","unstructured":"Twardowski ZJ. Clinical value of standardized equilibration tests in CAPD patients. Blood Purif. 2008;7(2):95\u2013108. https:\/\/doi.org\/10.1159\/000169582.","journal-title":"Blood Purif"},{"issue":"4","key":"5110_CR24","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1159\/000169445","volume":"4","author":"RT Krediet","year":"2008","unstructured":"Krediet RT, Boeschoten EW, Zuyderhoudt FM, Strackee J, Arisz L. Simple assessment of the efficacy of peritoneal transport in continuous ambulatory peritoneal dialysis patients. Blood Purif. 2008;4(4):194\u2013203. https:\/\/doi.org\/10.1159\/000169445.","journal-title":"Blood Purif"},{"issue":"5","key":"5110_CR25","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1002\/jps.2600800520","volume":"80","author":"DA Noe","year":"1991","unstructured":"Noe DA. A body surface area nomogram based on the formula of Gehan and George. J Pharm Sci. 1991;80(5):501. https:\/\/doi.org\/10.1002\/jps.2600800520.","journal-title":"J Pharm Sci"},{"issue":"8","key":"5110_CR26","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.1097\/01.ASN.0000080316.37254.7A","volume":"14","author":"CC Szeto","year":"2003","unstructured":"Szeto CC, Wong TY, Chow KM, Leung CB, Li PK. Oral sodium bicarbonate for the treatment of metabolic acidosis in peritoneal dialysis patients: a randomized placebo-control trial. J Am Soc Nephrol. 2003;14(8):2119\u201326.","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"5110_CR27","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1681\/ASN.V75745","volume":"7","author":"RW van Olden","year":"1996","unstructured":"van Olden RW, Krediet RT, Struijk DG, Arisz L. Measurement of residual renal function in patients treated with continuous ambulatory peritoneal dialysis. J Am Soc Nephrol. 1996;7(5):745\u201350. https:\/\/doi.org\/10.1681\/ASN.V75745.","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"5110_CR28","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1177\/089686089801800502","volume":"18","author":"J Bergstr\u00f6m","year":"1998","unstructured":"Bergstr\u00f6m J, Heimb\u00fcrger O, Lindholm B. Calculation of the protein equivalent of total nitrogen appearance from urea appearance. Which formulas should be used? Perit Dial Int. 1998;18(5):467\u201373. https:\/\/doi.org\/10.1177\/089686089801800502.","journal-title":"Perit Dial Int"},{"issue":"10","key":"5110_CR29","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1093\/ndt\/8.10.1094","volume":"8","author":"G Enia","year":"1993","unstructured":"Enia G, Sicuso C, Alati G, Zoccali C. Subjective global assessment of nutrition in dialysis patients. Nephrol Dial Transpl. 1993;8(10):1094\u201398.","journal-title":"Nephrol Dial Transpl"},{"issue":"6","key":"5110_CR30","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1053\/ajkd.2001.29222","volume":"38","author":"K Kalantar-Zadeh","year":"2001","unstructured":"Kalantar-Zadeh K, Kopple JD, Block G, Humphreys MH. A malnutrition-inflammation score is correlated with morbidity and mortality in maintenance hemodialysis patients. Am J Kidney Dis. 2001;38(6):1251\u201363. https:\/\/doi.org\/10.1053\/ajkd.2001.29222.","journal-title":"Am J Kidney Dis"},{"issue":"12","key":"5110_CR31","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1093\/ajcn\/29.12.1359","volume":"29","author":"GB Forbes","year":"1976","unstructured":"Forbes GB, Bruining GJ. Urinary creatinine excretion and lean body mass. Am J Clin Nutr. 1976;29(12):1359\u201366. https:\/\/doi.org\/10.1093\/ajcn\/29.12.1359.","journal-title":"Am J Clin Nutr"},{"issue":"2","key":"5110_CR32","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1081\/JDI-120018724","volume":"25","author":"CC Szeto","year":"2003","unstructured":"Szeto CC, Chow KM, Leung CB, Wong TY, Li PK. Assessment of protein nitrogen appearance in Chinese peritoneal dialysis patients-which method to use? Ren Fail. 2003;25(2):235\u201346.","journal-title":"Ren Fail"},{"issue":"4","key":"5110_CR33","doi-asserted-by":"publisher","first-page":"409","DOI":"10.3747\/pdi.2013.00066","volume":"34","author":"BC Kwan","year":"2014","unstructured":"Kwan BC, Szeto CC, Chow KM, Law MC, Cheng MS, Leung CB, et al. Bioimpedance spectroscopy for the detection of fluid overload in Chinese peritoneal dialysis patients. Perit Dial Int. 2014;34(4):409\u201316.","journal-title":"Perit Dial Int"},{"issue":"2","key":"5110_CR34","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1159\/000335580","volume":"35","author":"CC Szeto","year":"2012","unstructured":"Szeto CC, Kwan BC, Chow KM, Leung CB, Law MC, Li PK. Prognostic value of arterial pulse wave velocity in peritoneal dialysis patients. Am J Nephrol. 2012;35(2):127\u201333.","journal-title":"Am J Nephrol"},{"issue":"9","key":"5110_CR35","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1093\/ckj\/sfac084","volume":"15","author":"F Yildirim","year":"2022","unstructured":"Yildirim F, Yildiz AB, Kanbay M. A promising tool: triglyceride-glucose index to stratify the risk of cardiovascular events in chronic kidney disease. Clin Kidney J. 2022;15(9):1653\u201356.","journal-title":"Clin Kidney J"},{"issue":"1","key":"5110_CR36","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1186\/s12944-024-02275-x","volume":"23","author":"G Zhao","year":"2024","unstructured":"Zhao G, Shang S, Tian N, Zhan X, Peng F, Wang X, et al. Associations between different insulin resistance indices and the risk of all-cause mortality in peritoneal dialysis patients. Lipids Health Dis. 2024;23(1):287. https:\/\/doi.org\/10.1186\/s12944-024-02275-x.","journal-title":"Lipids Health Dis"},{"issue":"9","key":"5110_CR37","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1093\/ckj\/sfac073","volume":"15","author":"B Quiroga","year":"2022","unstructured":"Quiroga B, Mu\u00f1oz Ramos P, S\u00e1nchez Horrillo A, Ortiz A, Valdivieso JM, Carrero JJ. Triglycerides-glucose index and the risk of cardiovascular events in persons with non-diabetic chronic kidney disease. Clin Kidney J. 2022;15(9):1705\u201312. https:\/\/doi.org\/10.1093\/ckj\/sfac073. Erratum in: Clin Kidney J.2023 Feb 06; 16(5):883.","journal-title":"Clin Kidney J"},{"issue":"1","key":"5110_CR38","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1186\/s12882-025-04305-x","volume":"26","author":"S Wan","year":"2025","unstructured":"Wan S, Zhu H, He D, Hu Y, Wang Z, Zhang Y. Prognostic value of the triglyceride-glucose index for continuous ambulatory peritoneal dialysis patients. BMC Nephrol. 2025;26(1):356. https:\/\/doi.org\/10.1186\/s12882-025-04305-x.","journal-title":"BMC Nephrol"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-026-05110-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-026-05110-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-026-05110-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T03:36:16Z","timestamp":1786937776000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12882-026-05110-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,10]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5110"],"URL":"https:\/\/doi.org\/10.1186\/s12882-026-05110-w","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,10]]},"assertion":[{"value":"10 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the Joint Chinese University of Hong Kong - New Territories East Cluster Clinical Research Ethics Committee (approval number CRE-2015.250 and CRE-2021.367). All study procedures were in accordance with the Declaration of Helsinki. All patients provided written informed consent.","order":1,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"480"}}